独家｜许鹏出任连尚集团首席执行官 加速AI战略纵深突破
Quick Answer
Xu Peng has been appointed CEO of LianShang Group starting May 2026, focusing on accelerating AI strategy and enhancing core business operations.
Quick Take
Xu Peng has been appointed CEO of LianShang Group starting May 2026, focusing on accelerating AI strategy and enhancing core business operations. Former CEO Luo Ming transitions to Global Business President, emphasizing a shift towards deeper AI integration and sustainable growth.
Key Points
- Xu Peng previously served as president of LianShang Group since 2021.
- LianShang Group aims to enhance its industry competitiveness through AI integration.
- Luo Ming will remain on the decision-making committee as vice-chairman.
- Xu Peng has extensive experience in digital culture and technology innovation.
- The management change is part of a strategic focus on sustainable development.
Article Excerpt
From source RSS / original summary据雷峰网获悉，连尚集团宣布，自2026年5月起，许鹏出任连尚集团首席执行官，并留任决策委员会管理执行委员，全权负责公司日常管理。 原连尚集团首席执行官罗铭将出任全球业务总裁，并留任决策委员会副主席。 许鹏2000年加入盛大集团，历任多款游戏制作人，构建起网络文化产品全链路开发与运营体系。 2014年出任上海果壳电子股份有限公司CEO，布局智能穿戴和移动互联网硬件创新。 2021年出任连尚集团总裁，全面统筹公司战略规划，推动数字文化内容创新与技术升级，持续提升公司在媒体传播领域的行业影响力。 据雷峰网了解，连尚集团本次管理层调整，是加速AI战略落地、推动核心业务向纵深领域聚焦突破的关键布局。 未来，连尚集团将充分激活企业内生发展动力，依托专业管理与业务能力，持续夯实行业竞争力，稳步实现高质量、可持续发展。
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from 雷峰网 AI
See more →
从诺奖项目到生成式药物设计，Latent Labs 创始人 Simon Kohl：AI 正在让生物学进入「可编程时代」 | CVPR 2026
Simon Kohl, CEO of Latent Labs, presented at CVPR 2026, highlighting how generative AI, including models like Latent-X1 and Latent-Y, is revolutionizing drug design by drastically reducing development times and costs, achieving up to 90% success rates compared to traditional methods. The transition from AlphaFold 2's structural predictions to autonomous design agents marks a pivotal shift towards programmable biology.
